Description: Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabinoid-glycoside compounds created using its proprietary enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions with an initial focus on inflammatory bowel disease. The company also engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.
Home Page: malachiteinnovations.com
200 Park Avenue
Cleveland,
OH
44122
United States
Phone:
216 304 6556
Officers
| Name | Title |
|---|---|
| Mr. Michael R. Cavanaugh CPA, J.D. | CEO & Director |
| Dr. Brandon Joel Zipp Ph.D. | Scientific Co-Founder & Chief Science Officer |
| Mr. Richard McKilligan J.D., M.B.A. | CFO, Counsel & Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.6919 |
| Price-to-Sales TTM: | 8.0394 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 23 |